United Therapeutics Corporation Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
United Therapeutics Corporation (UTHR) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $700.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-02-25
- United Therapeutics Corporation unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $700.00K.
- United Therapeutics Corporation unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was -$600.00K, a 166.67% decline from fiscal 2023.
- United Therapeutics Corporation unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $900.00K, a 125.00% increase from fiscal 2022.
- United Therapeutics Corporation unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $400.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $700.00K 10-K · filed 2026-02-25 |
| 2024-12-31 | -$600.00K 10-K · filed 2026-02-25 |
| 2023-12-31 | $900.00K 10-K · filed 2026-02-25 |
| 2022-12-31 | $400.00K 10-K · filed 2025-02-26 |
| 2021-12-31 | -$100.00K 10-K · filed 2024-02-21 |
| 2020-12-31 | $300.00K 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |